These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 17904790

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.
    Mousa NA, Crystal P, Wolfman WL, Bedaiwy MA, Casper RF.
    Menopause; 2008; 15(5):875-84. PubMed ID: 18480735
    [Abstract] [Full Text] [Related]

  • 46. The potential adverse effects of aromatase inhibitors on wound healing: in vitro and in vivo evidence.
    Howgate DJ, Gamie Z, Panteliadis P, Bhalla A, Mantalaris A, Tsiridis E.
    Expert Opin Drug Saf; 2009 Sep; 8(5):523-35. PubMed ID: 19645634
    [Abstract] [Full Text] [Related]

  • 47. Update on identifying and managing osteoporosis in women with breast cancer.
    Yamamoto DS, Viale PH.
    Clin J Oncol Nurs; 2009 Oct; 13(5):E18-29. PubMed ID: 19793700
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Estrogen and androgen play distinct roles in bone turnover in male mice before and after reaching sexual maturity.
    Matsumoto C, Inada M, Toda K, Miyaura C.
    Bone; 2006 Feb; 38(2):220-6. PubMed ID: 16213803
    [Abstract] [Full Text] [Related]

  • 50. Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19).
    Muftuoglu Y, Mustata G.
    Bioorg Med Chem Lett; 2010 May 15; 20(10):3050-64. PubMed ID: 20413308
    [Abstract] [Full Text] [Related]

  • 51. [The use of aromatase inhibitors in children].
    Eyal O, Naugolny L, Weintrob N.
    Harefuah; 2009 Dec 15; 148(12):825-30, 855. PubMed ID: 20088436
    [Abstract] [Full Text] [Related]

  • 52. Aromatase inhibition and inactivation.
    Brodie A, Long B.
    Clin Cancer Res; 2001 Dec 15; 7(12 Suppl):4343s-4349s; discussion 4411s-4412s. PubMed ID: 11916223
    [Abstract] [Full Text] [Related]

  • 53. Use of aromatase inhibitors to increase final height.
    Dunkel L.
    Mol Cell Endocrinol; 2006 Jul 25; 254-255():207-16. PubMed ID: 16766117
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Bone scan alterations in aromatase inhibitor-treated patients.
    De Geeter F, Van den Bruel A, De Cuypere E, Langlois M.
    Clin Nucl Med; 2015 Jan 25; 40(1):38-40. PubMed ID: 25290288
    [Abstract] [Full Text] [Related]

  • 56. First dual aromatase-steroid sulfatase inhibitors.
    Woo LW, Sutcliffe OB, Bubert C, Grasso A, Chander SK, Purohit A, Reed MJ, Potter BV.
    J Med Chem; 2003 Jul 17; 46(15):3193-6. PubMed ID: 12852749
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [Bone metabolisms of aromatase-knockout mice in male].
    Inada M, Miyaura C.
    Clin Calcium; 2006 Mar 17; 16(3):469-73. PubMed ID: 16508130
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.